Oct 23, 2013 · In the United States alone, the number of biospecimens is estimated to have tripled over a decade to reach approximately 600 million in 2010 . Furthermore, there has been a rapid evolution of increasingly affordable “next-generation” technologies that permit global or targeted evaluation of the genome, epigenome, proteome, and metabolome of ...
Get Price